Physicians' Academy for Cardiovascular Education

5 Things a cardiologist should know about diabetes

This series is aimed to guide cardiologists in management of patients with type 2 diabetes, since the cardiology practice is increasingly confronted with these patients. This series covers five topics by 5 experts that help understand what is important when treating patients with diabetes, and what risks these patients face.

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

Key classes of antidiabetic drugs – How do they work?

10' education - Feb. 14, 2018 - Prof Cliff Bailey - Birmingham, UK - Online CME

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy
Download your free copy

This document covers five topics that help cardiologists understand what is important when treating patients with diabetes, and which risks these patients face. Download your free copy.

Hypoglycemia in cardiovascular medicine: why worry?

5 Things a cardiologist needs to know about diabetes

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME
Several factors make a diabetes patient more vulnerable to severe hypoglycemia events, which are associated with higher CV morbidity and mortality. Prof Schernthaner discusses how hypoglycemia can be prevented.

5 Things a cardiologist needs to know about diabetes Several factors make a diabetes patient more vulnerable to severe hypoglycemia events, which are associated with higher CV morbidity and mortality. Prof Schernthaner discusses how hypoglycemia can be prevented.

Key classes of antidiabetic drugs – How do they work?

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof Cliff Bailey - Birmingham, UK - Online CME
Multiple causal pathways contribute to development of T2DM, thus various processes may be targeted to improve glucose regulation. Prof. Bailey briefly summarises the available therapeutic options.

5 Things a cardiologist needs to know about diabetes Multiple causal pathways contribute to development of T2DM, thus various processes may be targeted to improve glucose regulation. Prof. Bailey briefly summarises the available therapeutic options.

Diabetes cardiovascular outcome trials

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof. Lawrence Leiter, MD - Toronto, ON, Canada - Online CME
Prof Leiter gives an update of the trials on new antihyperglycemic drugs that have been completed or are ongoing since the FDA mandated demonstration of CV safety. Trials evaluating DPP-4 inhibitors, GLP-1 receptor agonists and SGLT2 inhibitors on CV outcomes are being discussed.

5 Things a cardiologist needs to know about diabetes Prof Leiter gives an update of the trials on new antihyperglycemic drugs (DPP-4 inhibitors, GLP-1 receptor agonists and SGLT2 inhibitors) that have been completed or are ongoing since the FDA mandated demonstration of CV safety.

HbA1c in CVD

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 14, 2018 - Prof Naveed Sattar, MD - University of Glasgow, United Kingdom
Prof Naveed Sattar discusses the value of HbA1c to diagnose T2DM, and how HbA1c levels are related to the risk of developing micro and macrovascular disease and the consequences thereof for choosing a HbA1c therapeutic target.

5 Things a cardiologist needs to know about diabetes Prof Naveed Sattar discusses the value of HbA1c to diagnose T2DM, and how HbA1c levels are related to the risk of developing micro and macrovascular disease and the consequences thereof for choosing a HbA1c therapeutic target.

Natural history of DM: Focus on micro- and macrovascular complications

5 Things a cardiologist needs to know about diabetes

10' education - Feb. 13, 2018 - Prof. Kausik Ray, Imperial College Londen, UK - Online CME
Prof. Ray focuses on micro- and macrovascular disease in type 2 diabetes, their implications, their interrelationship and how these risks can be modified by new glucose-lowering agents.

5 Things a cardiologist needs to know about diabetes Prof. Ray focuses on micro- and macrovascular disease in type 2 diabetes, their implications, their interrelationship and how these risks can be modified by new glucose-lowering agents.

Summary: Key classes of antidiabetic drugs

Feb. 1, 2018

After diagnosis of diabetes, glucose control is not the only factor that needs consideration, as CV risk and co-morbidities also require attention. The aim of therapy for T2DM is to improve glycemic control to reduce microvascular risk, and to lower macrovascular risk, mostly by control of lipids and BP. In addition, co-morbidities such as obesity, depression, fatty liver, and microvascular complications like kidney, eye and neuropathic diseases should be managed.

Summary: HbA1c in Cardiovascular Disease

Feb. 1, 2018

HbA1c is a measure used in diagnosis and management of diabetes. HbA1c is glycated hemoglobin, which refers to hemoglobin bound to glucose. Measurement of HbA1c levels reflects the average glucose level of the last 2-3 months, since red blood cells survive for 8 to 12 weeks before they are renewed

Summary: Natural history of diabetes: focus on microvascular and macrovascular complications

Feb. 1, 2018

The prevalence of type 2 diabetes (T2DM) is increasing: 150-200 million new cases are predicted in the next 10-15 years with the heaviest burden in less developed countries. Insulin resistance starts with weight gain and obesity, and can lead to hyperinsulinemia, hypertension, abnormal lipid levels, and altered clotting that can finally lead to T2DM

Summary: T2DM and Cardiovascular Outcomes

Jan. 1, 2018

Since the US Food and Drug Administration (FDA) mandated demonstration of CV safety for new antihyperglycemic drugs, various trials evaluating DPP-4 inhibitors, GLP-1RAs and SGLT2 inhibitors on CV outcomes have been completed or are ongoing. Results will be briefly discussed and are summarized in table 1.

5 Things a cardiologist should know about diabetes
5 Things a cardiologist should know about diabetes